Projects per year
Personal profile
Biography
Dr. Merlin Robb serves as Senior Vice President and Chief Medical Officer for the Henry M. Jackson Foundation for the Advancement of Military Medicine. As CMO, Dr. Robb advises HJF leadership and staff on medical and public health matters, including COVID-19 workforce protection protocols.
Dr. Robb served as the HJF HIV Program Director for the U.S. Military HIV Research Program (MHRP) from 2002 to 2019. While in the military, LTC Robb served in the MHRP and occupied a leadership role in the Department of Vaccine Development, MHRP, Walter Reed Army Institute of Research (WRAIR) from 1990 to 2002.
Dr. Robb is a board-certified pediatric infectious disease specialist with research experience in molecular biology; neutralizing antibody assay development; perinatal and pediatric HIV research; HIV correlates of protection research; HIV immuno-therapeutic trials; the design and conduct of Phase I, II and III clinical trials; and the strategic planning and organization of full vaccine development programs for East Africa and Asia. Dr. Robb was co-chair of the vaccine development group in “Operation Warp Speed” as part of US government team leading COVID-19 vaccine development serving as an IPA at WRAIR from 2020 through 2022.
Dr. Robb has over 430 peer reviewed articles which include COVID-19, HIV, Ebola, MERS-CoV, Anthrax and Zika-related research. He serves on numerous scientific and safety monitoring boards overseeing key program investments and pivotal protocols funded by the USG.
Dr. Robb serves as Professor of Pediatrics, Department of Pediatrics, Uniformed Services University of Health Sciences (USU), Bethesda, Md., and as Infectious Disease Specialist, Pediatric Infectious Disease Fellowship, USU and Walter Reed Army Medical Center, Washington, DC.
Dr. Robb completed his internship and residency from 1981 to 1984 at Madigan Army Medical Center, Tacoma, Wash., and was a Fellow in Pediatrics Infectious Diseases at Walter Reed Army Medical Center, Washington, DC. from 1988 to 1990. He graduated from Baylor College of Medicine with his M.D. degree in 1981.
Fingerprint
Dive into the research topics where Merlin Robb is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 5 Finished
-
Targeting HIV reservoirs in children with HIVIS DNA and MVA-CMDR vaccines
Robb, M., Ananworanich, J. & Palma, P.
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
1/02/18 → 28/02/25
Project: Research
-
Determinants of Resilience in Youth with HIV infection and Youth affected by HIV
Robb, M. & Ananworanich, J.
NATIONAL INSTITUTE OF MENTAL HEALTH
12/09/14 → 31/07/20
Project: Research
-
The Latent HIV Reservoir in Early-treated Thai Children
Robb, M., Ananworanich, J. & Puthanakit, T.
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
15/05/14 → 30/04/21
Project: Research
-
The Military HIV Research Program (MHRP) Clinical Trial Unit
Robb, M., Ake, J. J. A., Ake, J. A., Gramzinski, R. A. & Michael, N. L.
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES, National Institute of Allergy and Infectious Diseases
10/12/13 → 30/11/22
Project: Research
-
EPIDEMIOLOGY AND BIOLOGY OF HIV-1 PERINATAL TRANSMISSION
National Institute of Child Health and Human Development
30/09/96 → 31/12/01
Project: Research
-
HIV Knowledge, Information Sources, and Perceived Risk among Reproductive-Aged Individuals in Kisumu, Kenya: A Latent Profile Analysis
RV393 Study Group, Jan 2026, In: AIDS and Behavior. 30, 1, p. 282-290 9 p.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
CD16 and CD57 expressing gamma delta T cells in acute HIV-1 infection are associated with the development of neutralization breadth
for the RV217 Study Group, Jan 2025, In: PLoS Pathogens. 21, 1, e1012916.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations -
Ebola virus vaccination elicits Ebola virus–specific immune responses without substantial cross-reactivity to other filoviruses
Mdluli, T., Wollen-Roberts, S., Merbah, M., Beckman, B., Li, Y., Alrubayyi, A., Curtis, D. J., Shubin, Z., Barrera, M. D., Boeckelman, J., Duncan, S., Thapa, P., Kim, D., Costanzo, M. C., Bai, H., Dearlove, B. L., Hooper, J. W., Kwilas, S. A., Paquin-Proulx, D., Eller, M. A., & 20 others, 2 Apr 2025, In: Science Translational Medicine. 17, 792, eadq2496.Research output: Contribution to journal › Article › peer-review
3 Scopus citations -
High peak viraemia followed by spontaneous HIV-1 control in women living with HIV-1 subtype A1 in East Africa
Li, Y., Dearlove, B. L., Lewitus, E., Bai, H., Shangguan, S., Pham, P., Bose, M., Sanders-Buell, E., Miller, S. H., Rosario, Y., Ehrenberg, P. K., Tovanabutra, S., Thomas, R., Ake, J. A., Vasan, S., Eller, L. A., Nitayaphan, S., Maganga, L., Kibuuka, H., Sawe, F. K., & 2 others, Aug 2025, In: Journal of the International AIDS Society. 28, 8, e70016.Research output: Contribution to journal › Article › peer-review
Open Access -
Impact of Age of Sexual Debut on HIV Care Engagement Among Sexual and Gender Minorities in Nigeria
TRUST/RV368 Study Group, 1 Mar 2025, In: Journal of Acquired Immune Deficiency Syndromes. 98, 3, p. 242-251 10 p.Research output: Contribution to journal › Article › peer-review
Open Access
Press/Media
-
-
New HIV/AIDS Findings from Armed Forces Research Institute of Medical Sciences Reported [Vaccine Induced Seroreactivity Following Administration of Alvac-hiv/aidsvax®b/e Identified By Common Anti-hiv Test Kits and Algorithms In Thailand]
Nelson L. Michael, Robert J. O'Connell & Merlin Robb
24/10/25
1 item of Media coverage
Press/Media